Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-18, Stock:ABBV, The news for the past five days is as follows:
2018-01-10: NEWS1: Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar.NEWS2: AbbVie’s Rova-T: Can Label Expansion Make It a Blockbuster Drug?.NEWS3: Analysts’ Recommendations for Incyte in January 2018.NEWS4: Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar.NEWS5: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 11, 2018.NEWS6: Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference in Focus.NEWS7: AbbVie’s Rova-T and the Treatment of Small Cell Lung Cancer.NEWS8: Why AbbVie Wants Imbruvica to Be a Foundation Therapy in Hematologic Oncology.NEWS9: Better Stock: AbbVie Inc (ABBV) vs. Johnson & Johnson (JNJ).NEWS10: AbbVie’s Rova-T: Solid Growth Driver for the Future?.NEWS11: AbbVie’s Position in the Growing Oncology Market in 2018.NEWS12: Ex-Dividend Alert: AbbVie Raised its Dividend by 11%; Will Trade Ex-Dividend on January 11, 2018.NEWS13: Better Stock: AbbVie Inc (ABBV) vs. Johnson & Johnson (JNJ).NEWS14: LPCN Awaits FDA Panel Vote Today, APHB Slumps, BGNE Crosses $100 Again.NEWS15: LPCN Awaits FDA Panel Vote Today, APHB Slumps, BGNE Crosses $100 Again.NEWS16: AbbVie's Upadacitinib Gains Breakthrough Therapy Designation.
2018-01-11: NEWS1: Why TG Therapeutics Rallied 15.7% Today.NEWS2: Jeff Sessions is Taking Some Steam Out of the Marijuana Stocks Rally.NEWS3: Earnings Season Watch List: AbbVie.NEWS4: FDA Advisers Slam Lipocine's Testosterone Pill, Raising Doubts About 'Low T' Drugs.NEWS5: Mavyret May Prove a Strong Growth Driver for AbbVie Going Forward.NEWS6: Elagolix May Advance the Treatment Paradigm in Women’s Health.NEWS7: Jeff Sessions is Taking Some Steam Out of the Marijuana Stocks Rally.NEWS8: Here's What AbbVie's Management Just Said About Its Future.NEWS9: Miles White's Bold Moves Made Abbott Laboratories A Global Force.NEWS10: 7 Must-See Numbers from AbbVie's J. P. Morgan Presentation.NEWS11: Here&apos;s What AbbVie&apos;s Management Just Said About Its Future.NEWS12: How Ionis’s Spinraza Performed in 3Q17.NEWS13: Miles White&apos;s Bold Moves Made Abbott Laboratories A Global Force.NEWS14: 7 Must-See Numbers From AbbVie&apos;s J. P. Morgan Presentation.NEWS15: Earnings Season Watch List: AbbVie.
2018-01-12: NEWS1: Gauging Marijuana Risk: The Potential Investment Blowback.NEWS2: The Arrival of Marijuana.NEWS3: SPY, BA, DIS, ABBV: ETF Inflow Alert.NEWS4: Should You Jump on the Marijuana Bandwagon?.NEWS5: 3 of the Best Dividend Aristocrats for Retirement.NEWS6: 2017 Was a Year to Forget for Gilead Sciences, Inc., but This Year Could Be Better.NEWS7: 2017 Was a Year to Forget for Gilead Sciences, Inc., but This Year Could Be Better.NEWS8: AbbVie to Host Fourth-Quarter 2017 Earnings Conference Call.NEWS9: 3 of the Best Dividend Aristocrats for Retirement.
2018-01-16: NEWS1: Novartis (NVS) Announces Acceptance of Humira BLA by the FDA.NEWS2: Novartis (NVS) Announces Acceptance of Humira BLA by the FDA.NEWS3: See what the IHS Markit Score report has to say about AbbVie Inc..
2018-01-17: NEWS1: AbbVie Named Top Dividend Stock With Insider Buying and 2.77% Yield (ABBV).NEWS2: Is Gilead Sciences, Inc. a Buy in 2018?.NEWS3: Is Gilead Sciences, Inc. a Buy in 2018?.

Answer: Decrease